Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial

IMPORTANCE: RimabotulinumtoxinB (RIMA) may be preferable as an anti-sialorrhea treatment compared with current oral anticholinergic drugs in people with neurological disorders. OBJECTIVE: To assess the safety, efficacy, and tolerability of RIMA injections for the treatment of sialorrhea in adults. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaacson, Stuart H., Ondo, William, Jackson, Carlayne E., Trosch, Richard M., Molho, Eric, Pagan, Fernando, Lew, Mark, Dashtipour, Khashayar, Clinch, Thomas, Espay, Alberto J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990829/
https://www.ncbi.nlm.nih.gov/pubmed/31930364
http://dx.doi.org/10.1001/jamaneurol.2019.4565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990829/
https://www.ncbi.nlm.nih.gov/pubmed/31930364
http://dx.doi.org/10.1001/jamaneurol.2019.4565

Ejemplares similares